HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 189.14 Million CNY | 18.99% |
| 2022 | 159.5 Million CNY | 20.16% |
| 2021 | 132.75 Million CNY | 42.21% |
| 2020 | 93.35 Million CNY | -11.61% |
| 2019 | 105.6 Million CNY | 26.69% |
| 2018 | 83.35 Million CNY | 21.09% |
| 2017 | 68.83 Million CNY | 0.37% |
| 2016 | 68.58 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 58.81 Million CNY | 21.2% |
| 2024 Q2 | 50.97 Million CNY | 3.65% |
| 2024 Q1 | 49.17 Million CNY | 9.99% |
| 2023 Q3 | 53.15 Million CNY | 3.67% |
| 2023 FY | 189.8 Million CNY | 18.99% |
| 2023 Q4 | 44.7 Million CNY | -15.88% |
| 2023 Q2 | 51.27 Million CNY | 26.06% |
| 2023 Q1 | 40.67 Million CNY | -3.47% |
| 2022 FY | 159.5 Million CNY | 20.16% |
| 2022 Q3 | 45.8 Million CNY | 16.25% |
| 2022 Q2 | 39.4 Million CNY | 22.46% |
| 2022 Q1 | 32.17 Million CNY | -28.39% |
| 2022 Q4 | 42.13 Million CNY | -8.01% |
| 2021 FY | 132.75 Million CNY | 42.21% |
| 2021 Q4 | 44.92 Million CNY | 42.2% |
| 2021 Q3 | 31.59 Million CNY | 12.36% |
| 2021 Q2 | 28.11 Million CNY | 0.05% |
| 2021 Q1 | 28.1 Million CNY | -6.01% |
| 2020 FY | 93.35 Million CNY | -11.61% |
| 2020 Q4 | 29.9 Million CNY | 29.74% |
| 2020 Q3 | 23.04 Million CNY | 3482.59% |
| 2020 Q1 | -26.95 Million CNY | -183.11% |
| 2020 Q2 | 643.33 Thousand CNY | 102.39% |
| 2019 FY | 105.6 Million CNY | 26.69% |
| 2019 Q4 | 32.43 Million CNY | 29.43% |
| 2019 Q3 | 25.05 Million CNY | 152.97% |
| 2019 Q2 | -47.3 Million CNY | -19.29% |
| 2019 Q1 | -39.65 Million CNY | 0.0% |
| 2018 FY | 83.35 Million CNY | 21.09% |
| 2017 FY | 68.83 Million CNY | 0.37% |
| 2016 FY | 68.58 Million CNY | 0.0% |